Intravascular imaging and guidance technology — the IVUS (intravascular ultrasound), OCT (optical coherence tomography), CO2 angiography, and cone-beam CT creating the real-time visualization enabling more precise peripheral intervention — represents an important and growing peripheral intervention market dimension, with the Peripheral Intervention Market reflecting imaging guidance as a commercial value-add in peripheral procedures.

IVUS in peripheral intervention — the intravascular ultrasound enabling real-time vessel sizing, plaque characterization, stent apposition assessment, and venous outflow obstruction characterization — creates growing clinical adoption beyond its established coronary application. Volcano (Philips), Boston Scientific iLab, and Acist SyncVision providing peripheral IVUS with venous application growing from iliac vein stenting standardization recommendations.

CO2 angiography — the carbon dioxide as contrast agent substitute for patients with severe contrast allergy or renal impairment — represents the specialized imaging alternative enabling peripheral intervention in high-risk patients who cannot receive iodinated contrast. The CDS CO2 injection systems and digital subtraction angiography techniques specifically adapted for CO2 use.

Cone-beam CT (CBCT) in hybrid OR — the intraoperative cone-beam CT providing three-dimensional anatomical roadmapping during complex peripheral vascular procedures — represents the premium imaging infrastructure at hybrid operating rooms. Philips Allura, Siemens Artis, and GE Discovery fluoroscopy systems with CBCT capability enabling three-dimensional procedure planning during endovascular repair.

Do you think IVUS guidance will become mandatory for iliac vein stenting and EVAR procedures as clinical evidence grows for improved outcomes with intravascular imaging?

FAQ

What is IVUS and how is it used in peripheral intervention? IVUS (intravascular ultrasound): catheter-based ultrasound probe (20-40 MHz); real-time cross-sectional vessel imaging; peripheral applications: iliac vein stenting (size assessment, apposition verification); EVAR (access vessel assessment, proximal neck sizing, stent graft apposition); PAD intervention (plaque characterization, calcium assessment, dissection detection); advantages: superior vessel sizing vs angiography; plaque morphology; contrast-free; growing venous adoption from IVUS-guided iliac stenting evidence (superior sizing and placement); major vendors: Volcano (Philips) Revolution, Boston Scientific iLab, Acist; peripheral IVUS growing from venous intervention.

What is a hybrid operating room and what imaging does it contain? Hybrid OR: surgical suite combining advanced cardiovascular fluoroscopic imaging with full surgical capability; imaging: fixed ceiling-mounted flat-panel fluoroscopy system (Philips Allura, Siemens Artis Q, GE Discovery IGS); cone-beam CT capability; angiography table (carbon fiber, patient repositioning); full surgical lighting, anesthesia, and scrub setup; applications: complex EVAR/FEVAR requiring surgical exposure plus endovascular; TCAR; carotid surgery with backup CAS; peripheral bypass plus endovascular hybrid procedure; redo cardiac surgery; commercial investment: $2-4 million per hybrid OR; approximately five hundred US hybrid ORs; growing from complex endovascular procedure volume.

#PeripheralIntervention #IVUS #HybridOR #ConeBeamCT #IntravascularImaging #EndovascularImaging